middle.news
CSL Delivers Steady Growth, Reaffirms FY25 Earnings Guidance
9:05am on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
CSL Delivers Steady Growth, Reaffirms FY25 Earnings Guidance
9:05am on Monday 2nd of June, 2025 AEST
Key Points
5% revenue growth to US$8.47 billion at constant currency
7% increase in net profit after tax (NPAT) to US$2.04 billion
Strong performance in CSL Behring and Vifor segments
Seqirus segment impacted by low immunisation rates and competitive pressures
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CSL (ASX:CSL)
OPEN ARTICLE